Tripelennamine (Tripelennamine Hydrochloride)
A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
Also Known As:
Tripelennamine Hydrochloride; Pyribenzamine; Tripelennamine Citrate; Azaron; Histantin; Tripelennamine Citrate (1:1); Tripelennamine Maleate; Tripelennamine Maleate (1:1); Tripelennamine Monohydrochloride; Vetibenzamin; 1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-
Networked: 137
relevant articles (2 outcomes,
5 trials/studies)
Relationship Network
Drug Context: Research Results
Experts
1. | ACAAI-ACOG(American College of Allergy, Asthma, and Immunology and American College of Obstetricians and Gynecologists.):
1 article
(06/2003)
|
2. | Blaiss, Michael S:
1 article
(06/2003)
|
3. | Food and Drug Administration (U.S.):
1 article
(06/2003)
|
4. | Depuy, Tracy:
1 article
(04/2002)
|
5. | Goetz, Thomas E:
1 article
(04/2002)
|
6. | Humphrey, Sarah:
1 article
(04/2002)
|
7. | Manohar, Murli:
1 article
(04/2002)
|
8. | Abdel Hadi, A A:
1 article
(06/2000)
|
9. | Al Muharami, A M:
1 article
(06/2000)
|
10. | Alkatheeri, N A:
1 article
(06/2000)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures